Phase I clinical study of anti-apoptosis protein, survivin-derived peptide vaccine therapy for patients with advanced or recurrent colorectal cancer
<p>Abstract</p> <p>Survivin is a member of the inhibitor of apoptosis protein (IAP) family containing a single baculovirus IAP repeat domain. It is expressed during fetal development but becomes undetectable in terminally differentiated normal adult tissues. We previously reported...
Main Authors: | Minamida Hidetoshi, Mizushima Yasuhiro, Sasaki Kazuaki, Yasoshima Takahiro, Katsuramaki Tadashi, Yamaguchi Koji, Ohmura Tosei, Yagihashi Atsuhito, Yamamoto Masaaki, Kurotaki Takehiro, Idenoue Satomi, Furuhata Tomohisa, Torigoe Toshihiko, Hata Fumitake, Tsuruma Tetsuhiro, Kimura Hiromichi, Akiyama Morifumi, Hirohashi Yoshihiko, Asanuma Hiroko, Tamura Yasuaki, Shimozawa Kumiko, Sato Noriyuki, Hirata Koichi |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2004-06-01
|
Series: | Journal of Translational Medicine |
Online Access: | http://www.translational-medicine.com/content/2/1/19 |
Similar Items
-
Clinical and immunological evaluation of anti-apoptosis protein, survivin-derived peptide vaccine in phase I clinical study for patients with advanced or recurrent breast cancer
by: Asanuma Hiroko, et al.
Published: (2008-05-01) -
Comparative study on the immunogenicity between an HLA-A24-restricted cytotoxic T-cell epitope derived from survivin and that from its splice variant survivin-2B in oral cancer patients
by: Yamaguchi Akira, et al.
Published: (2009-01-01) -
Non-neoplastic Fallopian Tube Epithelium Carrying Gene Mutations of a Novel SOX2 Repressor Region is Soil of High-grade Serous Ovarian Cancer
by: Yoshihiko Hirohashi, et al.
Published: (2016-08-01) -
Phosphoregulation of survivin
by: Barrett, Rachel M. A.
Published: (2008) -
Study of Survivin and Anti-Survivin Antibody in Esophageal Carcinoma patients
by: Jen-Yu Chen, et al.
Published: (2002)